0001486189-22-000016.txt : 20220906 0001486189-22-000016.hdr.sgml : 20220906 20220906165219 ACCESSION NUMBER: 0001486189-22-000016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220901 FILED AS OF DATE: 20220906 DATE AS OF CHANGE: 20220906 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hosseinion Warren CENTRAL INDEX KEY: 0001438327 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41346 FILM NUMBER: 221228848 MAIL ADDRESS: STREET 1: C/O 1668 S. GARFIELD AVENUE STREET 2: 2ND FLOOR CITY: ALHAMBRA STATE: CA ZIP: 91801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nutex Health, Inc. CENTRAL INDEX KEY: 0001479681 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 113363609 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2455 EAST SUNRISE BLVD. STREET 2: SUITE 1204 CITY: FORT LAUDERDALE STATE: FL ZIP: 33304 BUSINESS PHONE: (954) 449-4703 MAIL ADDRESS: STREET 1: 2455 EAST SUNRISE BLVD. STREET 2: SUITE 1204 CITY: FORT LAUDERDALE STATE: FL ZIP: 33304 FORMER COMPANY: FORMER CONFORMED NAME: Clinigence Holdings, Inc. DATE OF NAME CHANGE: 20191113 FORMER COMPANY: FORMER CONFORMED NAME: iGambit, Inc. DATE OF NAME CHANGE: 20091230 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-09-01 0 0001479681 Nutex Health, Inc. NUTX 0001438327 Hosseinion Warren C/O NUTEX HEALTH INC. 6030 S. RICE AVE. SUITE C HOUSTON TX 77081 1 1 0 0 President Common Stock 2022-09-01 4 S 0 70000 2.564 A 978975 D Common Stock 2022-09-02 4 S 0 180000 2.4836 A 798975 D Common Stock 2022-09-06 4 S 0 100000 2.7883 A 698975 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.5445 to $2.5840, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4009 to $2.5031, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.7500 to $2.8271, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. /s/ Warren Hosseinion 2022-09-06